1. Fiarka, F., Hakim, A. R., Budiansah, I., Wicaksono, A. A., Jabar, J. M., Peters, S. M. B., Prive, B. M., Nagarajah, J., Konijnenberg, M. W., Siregar, S., Hardiansyah, D. and Glatting, G. (2026). "Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [177Lu]Lu-PSMA-617 Therapy." Zeitschrift für Medizinische Physik.Fiarka, F., Hakim, A. R., Budiansah, I., Wicaksono, A. A., Jabar, J. M., Peters, S. M. B., Prive, B. M., Nagarajah, J., Konijnenberg, M. W., Siregar, S., Hardiansyah, D. and Glatting, G. (2026). "Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [177Lu]Lu-PSMA-617 Therapy." Zeitschrift für Medizinische Physik.
  2. Fragoso-Negrín J-A, Vergara-Gil A, Rahman Hakim A, Hardiansyah D, Glatting G, Ferrer L, Varmenot N, Santoro L, Veloza-Awad S, Hébert K, Deshayes E, Bardiès M. OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry. J Nucl Med 2026; epub 2025: jnumed.125.269539.
  3. Hakim AR, Hardiansyah D, Yousefzadeh-Nowshahr E, Nemer U, Ritawidya R, Kind F, Beer AJ, Meyer PT, Glatting G, Mix M. Accuracy and precision of few-time-points renal dosimetry for [177Lu]Lu-PSMA-617 therapy: Analysis with nonlinear mixed-effects modeling. Med Phys 2026; 53(1): e70212.
  4. Hardiansyah D, Patrianesha BB, Shi K, Saboury B, Rahmim A, Glatting G. An Overview of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Models: Applications to Radiopharmaceutical Therapies for Analysis and Personalization. PET Clin 2026; 21(1): 89-100.
  5. Ivashchenko OV, O’Doherty J, Pérez García-Estañ T, Tran-Gia J, Hippeläinen E, Sandström M, Stokke C, Glatting G, Cremonesi M. Current practice in reporting internal dosimetry for [177Lu]Lu-DOTATATE therapy: a systematic review. Phys Med 2026; 146: 105808.
  6. Kratzer W, Steinkellner S, Skotnik D, Peters L, Gruener B, Eberhardt N. Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification. Nuklearmedizin 2026; 65: 4-12
  7. Maudah AHS, Hardiansyah D, Yousefzadeh-Nowshahr E, Allmann A, Marlina, Eiber M, Beer AJ, Glatting G. Global Sensitivity Analysis of Whole-Body Physiologically Based Pharmacokinetic Model Parameters in [177Lu]Lu-PSMA-I&T Radioligand Therapy: Key Determinants of Individual Kidney and Tumor Absorbed Dose Uncertainty and Implications for Digital Twin Development. IEEE Transactions on Radiation and Plasma Medical Sciences 2026: 1-.
  8. Ryhiner M, Song Y, Saboury B, Glatting G, Rahmim A, Shi K. Mathematical and Computational Nuclear Oncology: Toward Optimized Radiopharmaceutical Therapy via Digital Twins. PET Clin 2026; 21(1): 117-131.
  9. Vasić V, Gustafsson J, Yousefzadeh-Nowshahr E, Beer AJ, Sjögreen Gleisner K, Glatting G. [177Lu]Lu-DOTA-TATE tumour and organ timeactivity curves: prediction from a single-time-point [68Ga]Ga-DOTA-TATE PET/CT measurement. EJNMMI Phys 2026; epub 16.01.2026